Unknown Author
January 24, 2026
Freshfields advises AmerisourceBergen on acquisition of PharmaLex

1 min
AI-made summary
- Freshfields is advising AmerisourceBergen Corporation on its €1.28 billion cash acquisition of PharmaLex Holding GmbH, a provider of specialized services for the life sciences industry
- The cross-border Freshfields team includes M&A partners and associates from New York, Frankfurt, Dusseldorf, and London, with additional legal support on corporate, antitrust, compensation and benefits, tax, and regulatory matters provided by lawyers based in the US and Germany.
Freshfields is advising AmerisourceBergen Corporation (NYSE: ABC) on its €1.28bn cash acquisition of PharmaLex Holding GmbH, a leading provider of specialized services for the life sciences industry. More details about the transaction can be found here. The cross-border Freshfields team is led by M&A Partners Damien Zoubek (NY), Dr. Lars Meyer (Frankfurt) and Dr. Philipp Puetz (Dusseldorf) and Associate Sandy Ge (Dusseldorf). Additional support on corporate matters is provided by Associate Nicholas Lütgerath (NY) and Associate Gillian Farrell (London). Associates Jonas Braun (Dusseldorf) and Henri Conze (Dusseldorf) are providing support on German corporate matters. In the US, Partner Jan Rybnicek (Washington) and Special Counsel Charles Ramsey (Washington) are advising on antitrust matters; Partner Lori Goodman (NY) and Associates Jefferey Anand (NY) and Sonia Bennett (NY) are advising on compensation and benefits matters; and Partner Joe Solits (NY) is advising on tax matters. In Germany, Partner Michael Ramb (Dusseldorf) and Associate Katharina Reinhardt (Berlin) are advising on regulatory matters; Partner Thomas Granetzny (Dusseldorf) and Associate Tobias Kalb (Munich) are advising on compensation and benefits matters; and Partner Christian Ruoff (Hamburg) and Associate Dr. Anna Binder-Gutwinski (Vienna) are advising on tax matters.
Article Author
Unknown Author
The Sponsor
